Business

MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio

BURLINGTON, Mass., October 15, 2025--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, a leader in contract development and manufacturing, preclinical and translational clinical research, and bioprocessing solutions. The acquisition will e

articleMerck KgaaOctober 15, 20254/company/merck-kgaa/news/milliporesigma-to-acquire-chromatography-business-of-jsr-life-sciences-expanding-protein-a-capabilities-and-downstream-portfolio
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio

About this update from Merck Kgaa

[{"type":"image","alt":"JSR’s innovative Amsphere™ Protein A resin technology complements MilliporeSigma’s existing biologics portfolio","displaySize":"","headline":null,"caption":"JSR’s innovative Amsphere™ Protein A resin technology complements MilliporeSigma’s existing biologics portfolio","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/f6d5bf3e8fe7d81c2476b9d1437a1b01"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KI_qb62fExK6ApXp3UKcnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f6d5bf3e8fe7d81c2476b9d1437a1b01","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":274,"url":"https://media.zenfs.com/en/business-wire.com/28f119e55b30cb4740c3d91ffec8353a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Yj9.CD5f5SM2UysE0aqTjw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/28f119e55b30cb4740c3d91ffec8353a","width":480,"height":274}}},{"type":"list","items":[{"val":[{"type":"text","content":"Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions","length":120,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"JSR’s innovative Amsphere™ Protein A resin technology complements the company’s existing biologics portfolio","length":108,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Enhances the company’s capabilities to accelerate next-generation therapies by optimizing antibody purification","length":111,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":339,"olType":false},{"type":"text","content":"BURLINGTON, Mass., October 15, 2025--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business of Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, a leader in contract development and manufacturing, preclinical and translational clinical r...

More updates from Merck Kgaa

Merck KGaAMilliporeSigmaDarmstadt, GermanyLife ScienceLife Science businessmonoclonal antibodieschromatographyJSRJSR Life Sciencesmonoclonal antibody production